Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer - No Study Results Posted

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer (KHAD)

This study is ongoing, but not recruiting participants.

Study NCT00673127 Information provided by Dana-Farber Cancer Institute

First Received: May 5, 2008 Last Updated: April 22, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	February 2012 (Final data collection date for primary outcome measure)